Selected research
Industry Growth & Trends
Global AI Pharmaceutical Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global AI Pharmaceutical market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for AI Pharmaceutical is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for AI Pharmaceutical is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for AI Pharmaceutical is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the AI Pharmaceutical market include Noetik, Atomwise, Cradle, Exscientia, Iktos, Insilico Medicine, BenevolentAI, Cyclica and Recursion, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global AI Pharmaceutical market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The AI Pharmaceutical market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global AI Pharmaceutical market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to AI Pharmaceutical.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global AI Pharmaceutical market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
AI Pharmaceutical Market by Company
Noetik
Atomwise
Cradle
Exscientia
Iktos
Insilico Medicine
BenevolentAI
Cyclica
Recursion
Auransa
InveniAI
Pfizer
IBM
AI Pharmaceutical Segment by Type
Artificial intelligence (AI)
Machine Learning (ML)
Others
AI Pharmaceutical Segment by Application
Drug Discovery
Clinical Trials
Others
AI Pharmaceutical Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI Pharmaceutical market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of AI Pharmaceutical and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI Pharmaceutical.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of AI Pharmaceutical companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Artificial intelligence (AI)
- Machine Learning (ML)
- Others
Applications
- Drug Discovery
- Clinical Trials
- Others
Companies covered
- Noetik
- Atomwise
- Cradle
- Exscientia
- Iktos
- Insilico Medicine
- BenevolentAI
- Cyclica
- Recursion
- Auransa
- InveniAI
- Pfizer
- IBM
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global AI Pharmaceutical Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global AI Pharmaceutical Market Size by Region (2021-2032)
- 1.4.1 Global AI Pharmaceutical Market Size by Region (2021-2026)
- 1.4.2 Global AI Pharmaceutical Market Size by Region (2027-2032)
- 1.5 Key Regions AI Pharmaceutical Market Size (2021-2032)
- 1.5.1 North America AI Pharmaceutical Market Size Growth Rate (2021-2032)
- 1.5.2 Europe AI Pharmaceutical Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific AI Pharmaceutical Market Size Growth Rate (2021-2032)
- 1.5.4 South America AI Pharmaceutical Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa AI Pharmaceutical Market Size Growth Rate (2021-2032)
2 AI Pharmaceutical Market by Type
- 2.1 Type Introduction
- 2.1.1 Artificial intelligence (AI)
- 2.1.2 Machine Learning (ML)
- 2.1.3 Others
- 2.2 Global AI Pharmaceutical Market Size by Type
- 2.2.1 Global AI Pharmaceutical Market Size Overview by Type (2021-2032)
- 2.2.2 Global AI Pharmaceutical Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global AI Pharmaceutical Market Size Forecasted by Type (2027-2032)
- 2.3 Global AI Pharmaceutical Market Size by Regions
- 2.3.1 North America AI Pharmaceutical Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe AI Pharmaceutical Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific AI Pharmaceutical Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America AI Pharmaceutical Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa AI Pharmaceutical Market Size Breakdown by Type (2021-2026)
3 AI Pharmaceutical Market by Application
- 3.1 Type Introduction
- 3.1.1 Drug Discovery
- 3.1.2 Clinical Trials
- 3.1.3 Others
- 3.2 Global AI Pharmaceutical Market Size by Application
- 3.2.1 Global AI Pharmaceutical Market Size Overview by Application (2021-2032)
- 3.2.2 Global AI Pharmaceutical Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global AI Pharmaceutical Market Size Forecasted by Application (2027-2032)
- 3.3 Global AI Pharmaceutical Market Size by Regions
- 3.3.1 North America AI Pharmaceutical Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe AI Pharmaceutical Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific AI Pharmaceutical Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America AI Pharmaceutical Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa AI Pharmaceutical Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 AI Pharmaceutical Industry Trends
- 4.2 AI Pharmaceutical Industry Drivers
- 4.3 AI Pharmaceutical Industry Opportunities and Challenges
- 4.4 AI Pharmaceutical Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by AI Pharmaceutical Revenue (2021-2026)
- 5.2 Global AI Pharmaceutical Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global AI Pharmaceutical Key Company Headquarters & Area Served
- 5.4 Global AI Pharmaceutical Company, Product Type & Application
- 5.5 Global AI Pharmaceutical Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global AI Pharmaceutical Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 AI Pharmaceutical Players Market Share by Revenue in 2025
- 5.6.3 2025 AI Pharmaceutical Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Noetik
- 6.1.1 Noetik Company Information
- 6.1.2 Noetik Business Overview
- 6.1.3 Noetik AI Pharmaceutical Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Noetik AI Pharmaceutical Product Portfolio
- 6.1.5 Noetik Recent Developments
- 6.2 Atomwise
- 6.2.1 Atomwise Company Information
- 6.2.2 Atomwise Business Overview
- 6.2.3 Atomwise AI Pharmaceutical Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Atomwise AI Pharmaceutical Product Portfolio
- 6.2.5 Atomwise Recent Developments
- 6.3 Cradle
- 6.3.1 Cradle Company Information
- 6.3.2 Cradle Business Overview
- 6.3.3 Cradle AI Pharmaceutical Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Cradle AI Pharmaceutical Product Portfolio
- 6.3.5 Cradle Recent Developments
- 6.4 Exscientia
- 6.4.1 Exscientia Company Information
- 6.4.2 Exscientia Business Overview
- 6.4.3 Exscientia AI Pharmaceutical Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Exscientia AI Pharmaceutical Product Portfolio
- 6.4.5 Exscientia Recent Developments
- 6.5 Iktos
- 6.5.1 Iktos Company Information
- 6.5.2 Iktos Business Overview
- 6.5.3 Iktos AI Pharmaceutical Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Iktos AI Pharmaceutical Product Portfolio
- 6.5.5 Iktos Recent Developments
- 6.6 Insilico Medicine
- 6.6.1 Insilico Medicine Company Information
- 6.6.2 Insilico Medicine Business Overview
- 6.6.3 Insilico Medicine AI Pharmaceutical Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Insilico Medicine AI Pharmaceutical Product Portfolio
- 6.6.5 Insilico Medicine Recent Developments
- 6.7 BenevolentAI
- 6.7.1 BenevolentAI Company Information
- 6.7.2 BenevolentAI Business Overview
- 6.7.3 BenevolentAI AI Pharmaceutical Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 BenevolentAI AI Pharmaceutical Product Portfolio
- 6.7.5 BenevolentAI Recent Developments
- 6.8 Cyclica
- 6.8.1 Cyclica Company Information
- 6.8.2 Cyclica Business Overview
- 6.8.3 Cyclica AI Pharmaceutical Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Cyclica AI Pharmaceutical Product Portfolio
- 6.8.5 Cyclica Recent Developments
- 6.9 Recursion
- 6.9.1 Recursion Company Information
- 6.9.2 Recursion Business Overview
- 6.9.3 Recursion AI Pharmaceutical Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Recursion AI Pharmaceutical Product Portfolio
- 6.9.5 Recursion Recent Developments
- 6.10 Auransa
- 6.10.1 Auransa Company Information
- 6.10.2 Auransa Business Overview
- 6.10.3 Auransa AI Pharmaceutical Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Auransa AI Pharmaceutical Product Portfolio
- 6.10.5 Auransa Recent Developments
- 6.11 InveniAI
- 6.11.1 InveniAI Company Information
- 6.11.2 InveniAI Business Overview
- 6.11.3 InveniAI AI Pharmaceutical Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 InveniAI AI Pharmaceutical Product Portfolio
- 6.11.5 InveniAI Recent Developments
- 6.12 Pfizer
- 6.12.1 Pfizer Company Information
- 6.12.2 Pfizer Business Overview
- 6.12.3 Pfizer AI Pharmaceutical Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Pfizer AI Pharmaceutical Product Portfolio
- 6.12.5 Pfizer Recent Developments
- 6.13 IBM
- 6.13.1 IBM Company Information
- 6.13.2 IBM Business Overview
- 6.13.3 IBM AI Pharmaceutical Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 IBM AI Pharmaceutical Product Portfolio
- 6.13.5 IBM Recent Developments
7 North America
- 7.1 North America AI Pharmaceutical Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America AI Pharmaceutical Market Size by Country (2021-2026)
- 7.3 North America AI Pharmaceutical Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe AI Pharmaceutical Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe AI Pharmaceutical Market Size by Country (2021-2026)
- 8.3 Europe AI Pharmaceutical Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific AI Pharmaceutical Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific AI Pharmaceutical Market Size by Country (2021-2026)
- 9.3 Asia-Pacific AI Pharmaceutical Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America AI Pharmaceutical Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America AI Pharmaceutical Market Size by Country (2021-2026)
- 10.3 South America AI Pharmaceutical Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa AI Pharmaceutical Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa AI Pharmaceutical Market Size by Country (2021-2026)
- 11.3 Middle East & Africa AI Pharmaceutical Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst